Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus
95%
Cladistics
31%
Human Immunodeficiency Virus 2
28%
Genetic Variability
28%
Neutralizing Antibody
25%
Dynamics
24%
Drug Resistance
18%
Viral Load
17%
Antibody Response
16%
Phylogeny
16%
Glycoprotein
15%
Blood Plasma
14%
CXCR4
11%
Antibodies
11%
Immunology
11%
Epitope
10%
Mycobacterium Tuberculosis
10%
Env (Gene)
9%
Population Structure
7%
Prevalence
7%
Binding Antibody
7%
Hepatitis C Virus
7%
Genomic Surveillance
7%
Metagenomics
7%
Memory B Cell
7%
Drug Sensitivity
6%
Immunoglobulin A
6%
CD4
6%
Lineages
6%
Single-Domain Antibody
6%
Plasmodium
5%
Vaccinia Virus
5%
Neutralization
5%
Evolution
5%
IC50
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
57%
Global Disease Burden
46%
Drug Resistance
24%
Disease
22%
Injury
22%
Anti-Human Immunodeficiency Virus
19%
Prevalence
18%
Antimicrobial Agent
17%
Lactam
10%
Infection
8%
Human Immunodeficiency Virus 2
8%
Human Immunodeficiency Virus Fusion Inhibitor
7%
Hepatitis C
7%
Drug Carrier
7%
Mycobacterium Tuberculosis
7%
Human Immunodeficiency Virus 1
7%
Hepatitis B
7%
Polyethylene Glycol
7%
Nanoparticle
7%
Hepatitis C Virus
7%
Pharmacokinetics
7%
Fusion Inhibitor
7%
Hepatitis B Virus
6%
Cohort Study
6%
Plasmodium
5%
Antiplasmodial Activity
5%
Ethanol
5%
Antiinfective Agent
5%
Proteinase Inhibitor
5%
Medicine and Dentistry
Global Disease Burden
67%
Human Immunodeficiency Virus
36%
Diseases
31%
Injury
28%
Life Expectancy
19%
Prevalence
17%
Mortality Rate
15%
Genetic Variability
15%
Drug Resistance
14%
Disability Adjusted Life Years
14%
Health Care
12%
Low and Middle Income Countries
7%
Mental Capacity
7%
Human Immunodeficiency Virus 1
7%
Highly Active Antiretroviral Therapy
7%
Geographic Mapping
7%
Mycobacterium Tuberculosis
7%
Public Health
6%
Non Communicable Disease
6%
Reverse-Transcriptase Inhibitor
6%
Health System
6%
Infection
5%
Human Immunodeficiency Virus 2
5%
Population Structure
5%
Diarrhea
5%
